Original BioMedicals Has Received a Notification of Approval for the European Patent Titled "Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method."
Important News
Our company has received notification from the patent firm that the European Patent Certificate for “Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method” has been granted, under Application EP22204330.9.
Prev
Composition and Administration Method for Upper Respiratory Drug Delivery (OBM-B01), Developed by Original BioMedicals, Has Been Approved by TFDA for Phase I Clinical Trials
Human Clinical Trial Plan for Original BioMedicals B01 Cyanide Compound Drug (Patent: Composition for Upper Respiratory Tract Administration and Method) Has Been Approved by the Joint IRB of Taipei Medical University and Its Affiliated Hospital.
